RecruitingNot Applicable

Screening for Neurodevelopmental Disorders in Siblings of Children With Autism Diagnosed in Tertiary Centers

France384 participantsStarted 2023-11-28

Plain-language summary

In this study, a selective and multi-stages screening for neurodevelopmental disorders (NDD) in siblings of children with a confirmed ASD is done. The main aims are to estimate the prevalence of NDD among siblings and to evaluate the feasibility and acceptability of a standardized screening procedure.

Who can participate

Age range2 Years – 16 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Step 1: Brothers or sisters (including stepsisters and brothers); aged between 2 and 16 years; living in Occitanie; informed and express consent of parents ; affiliated to social security. * Step 2: step 1 positive screening or parental concerns for child's development ; parental signed informed consent. Exclusion Criteria: * Parents (or child) refusal to participate; adopted brother or sister. Do not speak French

What they're measuring

Percentage of family participation

Timeframe: 12 months

Trial details

NCT IDNCT05512637

SponsorUniversity Hospital, Montpellier

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-11

Contact for this trial

Cécile MICHELON

467330986 c-michelon@chu-montpellier.fr

View on ClinicalTrials.gov More Autism Spectrum Disorder trials